NCT00973973View on ClinicalTrials.gov

Efficacy and Safety Study of Elagolix in Women With Endometriosis

PHASE2CompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

October 12, 2009

Primary Completion Date

September 22, 2010

Study Completion Date

September 22, 2010

Conditions
Endometriosis, Pain
Interventions
DRUG

Placebo

Matching placebo tablets taken orally once a day

DRUG

Elagolix

Immediate release (IR) tablets taken orally once a day

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY